Veterinary Medicines

Dinolytic 5 mg/ml Oplossing voor injectie

Authorised
  • Dinoprost trometamol
Download as PDF

Product identification

Medicine name:
Dinolytic 5 mg/ml Oplossing voor injectie
Dinolytic 5 mg/ml Solution injectable
Dinolytic 5 mg/ml Injektionslösung
Active substance:
  • Dinoprost trometamol
Target species:
  • Horse
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Dinoprost trometamol
    6.70
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        no withdrawal period
  • Subcutaneous use
    • Horse
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        no withdrawal period
    • Cattle
      • Meat and offal
        2
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Dinolytic 10 x 5 ml Vials Solution for injection
  • Dinolytic 25 x 10 ml Vials Solution for injection
  • Dinolytic 5 x 10 ml Vial Solution for injection
  • Dinolytic 1 x 100 ml Vial Solution for injection
  • Dinolytic 1 x 30 ml Vial Solution for injection
  • Dinolytic 1 x 10 ml Vial Solution for injection
  • Dinolytic 1 x 5 ml Vial Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
  • Zoetis Belgium
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V094105
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/09/2023
Download
French (PDF)
Published on: 27/09/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/09/2023
Download
French (PDF)
Published on: 27/09/2023
Download
German (PDF)
Published on: 27/09/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 27/09/2023
Download
French (PDF)
Published on: 27/09/2023
Download
German (PDF)
Published on: 27/09/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."